These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19011424)

  • 1. Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort.
    de Boer-van der Kolk IM; Sprangers MA; van der Ende M; Schreij G; de Wolf F; Nieuwkerk PT
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):460-2. PubMed ID: 19011424
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving adherence to antiretroviral therapy.
    Daar ES; Cohen C; Remien R; Sherer R; Smith K
    AIDS Read; 2003 Feb; 13(2):81-2, 85-6, 88-90. PubMed ID: 12645492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to HAART: impressions from the 12th world AIDS conference, Geneva, June 28-July 3, 1998.
    Weiss JJ
    Patient Educ Couns; 1999 Mar; 36(3):287-9. PubMed ID: 14528564
    [No Abstract]   [Full Text] [Related]  

  • 7. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework.
    Horne R; Cooper V; Gellaitry G; Date HL; Fisher M
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):334-41. PubMed ID: 17514019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.
    Spire B; Duran S; Souville M; Leport C; Raffi F; Moatti JP;
    Soc Sci Med; 2002 May; 54(10):1481-96. PubMed ID: 12061483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.
    Rodríguez-Arenas MA; Jarrín I; del Amo J; Iribarren JA; Moreno S; Viciana P; Peña A; Sirvent JL; Vidal F; Lacruz J; Gutierrez F; Oteo JA; Asencio R; Castilla J; Hoyos SP;
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):715-23. PubMed ID: 16910826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of short-term success of antiretroviral therapy in HIV infection.
    Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
    J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bimodal virological response to antiretroviral therapy for HIV infection: an application using a mixture model with left censoring.
    Li X; Chu H; Gallant JE; Hoover DR; Mack WJ; Chmiel JS; Muñoz A
    J Epidemiol Community Health; 2006 Sep; 60(9):811-8. PubMed ID: 16905728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients.
    Maggiolo F; Ripamonti D; Arici C; Gregis G; Quinzan G; Camacho GA; Ravasio L; Suter F
    HIV Clin Trials; 2002; 3(5):371-8. PubMed ID: 12407486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART.
    Antinori A; Cozzi-Lepri A; Ammassari A; Trotta MP; Nauwelaers D; Hoetelmans R; Murri R; Melzi S; Narciso P; Nasta P; Zaccarelli M; Santopadre P; Vecchiet J; Izzo CM; Maonforte Ad;
    Antivir Ther; 2004 Apr; 9(2):291-6. PubMed ID: 15134192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: a qualitative study.
    Sidat M; Fairley C; Grierson J
    AIDS Patient Care STDS; 2007 Jul; 21(7):509-20. PubMed ID: 17651032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy.
    Quiros-Roldan E; Torti C; Lapadula G; Ladisa N; Micheli V; Patroni A; Cusato M; Pierotti P; Tirelli V; Uccelli MC; Di Giambenedetto S; Castelnuovo F; Gargiulo F; Manca N; Carosi G;
    AIDS Patient Care STDS; 2007 Feb; 21(2):92-9. PubMed ID: 17328658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs.
    Pradier C; Carrieri P; Bentz L; Spire B; Dellamonica P; Moreau J; Moatti JP
    Int J STD AIDS; 2001 May; 12(5):324-8. PubMed ID: 11368807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Take HAART: medication adherence in the era of highly active antiretroviral therapy.
    Allardice K
    Aust Nurs J; 2002 Apr; 9(9):19-21. PubMed ID: 12017049
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.
    Tuldrà A; Fumaz CR; Ferrer MJ; Bayés R; Arnó A; Balagué M; Bonjoch A; Jou A; Negredo E; Paredes R; Ruiz L; Romeu J; Sirera G; Tural C; Burger D; Clotet B
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):221-8. PubMed ID: 11115952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.